New Study: Fast, Effective EMS Option For Excited Delirium Cases

Print Friendly, PDF & Email

Preliminary results from a new, ongoing study tend to support a growing trend in the management of dangerous subjects in the throes of Excited Delirium Syndrome (ExDS).

The findings should be part of the dialog if you are working on a joint law enforcement/EMS protocol for addressing this perplexing problem, as recommended in Force Science News (4/9/12).

The study, being conducted by Dr. Michael Curtis, former EMS medical director for Portage County, WI, is documenting cases among seven Wisconsin ambulance services whose paramedics have administered the drug ketamine, a potent sedative, to physically violent individuals before transporting them to a hospital. Curtis, an ER physician in Stevens Point, WI, says more than 50 cases involving agitated and combative behavior have been noted so far. Roughly 80% met the descriptors for ExDS, he estimates.

Given in the proper dosage, ketamine has proven to be “extremely effective” in sedating almost all of these subjects into a calm, controllable state within three to five minutes, Curtis told FSN, adding that “all survived with no unexpected adverse side effects.” The sedation typically sustained for 20-30 minutes –long enough for the subjects to reach a medical facility where treatment to reduce their symptoms could be pursued.

Many experts believe that rapid calming reduces the extreme physiological stress caused by an extended struggle with police and continued agitation after restraint that contribute to the risk of death in ExDS events. “Moreover, before emergency medical professionals can deliver a lifesaving treatment, they have to initiate an IV, which is often impossible until the patient is made calm,” Curtis says.

Traditionally, ketamine has been used as an anesthetic or analgesic (pain reliever), Curtis explains. But of late, an increasing number of EMS units in the US have begun injecting it in ExDS subjects and other violent parties, once police have established sufficient restraint to allow it. The ideal dosage, Curtis says, appears to be 5 mg per kg of a subject’s weight (450 mg for a 200 lb. subject, for example). More can be administered if necessary without dire consequences, he says.

In a recently published paper, a team led by Dr. Jeffrey Ho, a prominent researcher of in-custody deaths, reports on two cases in which ketamine was used successfully as part of an ExDS response.

In one case, police were called to handle a 35-year-old chronic cokehead, partially nude in 11-degree weather, who was acting bizarrely and trying to enter a closed business. The cops found him raving nonsensically, “remarkably strong,” and unresponsive to manual pain-compliance. Even though eight officers eventually proned him out, he continued to bang his head on the pavement until an EMS responder delivered a 500-mg intramuscular injection of ketamine through his clothing and into his butt. Within four minutes, he was calm. He arrived alive at a hospital and there was “returned to normal” with no negative after-effects.

In the second case, police responded to a domestic and confronted a highly agitated, partly nude 40-year-old B/M with a history of schizophrenia and substance abuse. He was screaming requests to speak with God and engaged officers in “a significant fight” before he was Tasered into submission. The police had wisely summoned EMS early in the call, and once the subject was down a medic injected ketamine. This subject was calm in about three minutes–“overall success with no complications,” Ho writes. (An abstract of this study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/23231451)

“Law enforcement and EMS need to work together to handle excited delirium cases,” Curtis says. “Neither can do it alone. Police need to realize they are dealing with a medical/psychiatric emergency, and EMS needs to be prepared to move in quickly and get the subject sedated immediately and transported by ambulance to the ER. For best results, there has to be a community-wide protocol, involving agencies that are not always accustomed to working together.”

Curtis presented a preliminary report on the Wisconsin experience and a review of professional literature related to ketamine and ExDS at the latest annual conference of the Institute for the Prevention of In-Custody Deaths.

[Contact information: Dr. Curtis, Michael.Curtis@ministryhealth.org; Dr. Ho, jeffrey.ho@hcmed.org. Our thanks to attorney Michael Brave, president of LAAW International, for alerting us to these studies.]

Leave a Reply


  • Privacy Policy

Privacy Policy

Effective date: January 06, 2019

Force Science Institute, Ltd. (“us”, “we”, or “our”) operates the https://www.forcescience.org/ website (hereinafter referred to as the “Service”).

This page informs you of our policies regarding the collection, use, and disclosure of personal data when you use our Service and the choices you have associated with that data. Our Privacy Policy for Force Science Institute, Ltd. is based on the Privacy Policy Template from Privacy Policies.

We use your data to provide and improve the Service. By using the Service, you agree to the collection and use of information in accordance with this policy. Unless otherwise defined in this Privacy Policy, the terms used in this Privacy Policy have the same meanings as in our Terms and Conditions, accessible from https://www.forcescience.org/

Information Collection And Use

We collect several different types of information for various purposes to provide and improve our Service to you.

Types of Data Collected

Personal Data

While using our Service, we may ask you to provide us with certain personally identifiable information that can be used to contact or identify you (“Personal Data”). Personally identifiable information may include, but is not limited to:

  • Email address
  • First name and last name
  • Phone number
  • Address, State, Province, ZIP/Postal code, City
  • Cookies and Usage Data

Usage Data

We may also collect information on how the Service is accessed and used (“Usage Data”). This Usage Data may include information such as your computer’s Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Service that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.

Tracking & Cookies Data

We use cookies and similar tracking technologies to track the activity on our Service and hold certain information.

Cookies are files with small amount of data which may include an anonymous unique identifier. Cookies are sent to your browser from a website and stored on your device. Tracking technologies also used are beacons, tags, and scripts to collect and track information and to improve and analyze our Service.

You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Service. You can learn more how to manage cookies in the Browser Cookies Guide.

Examples of Cookies we use:

  • Session Cookies. We use Session Cookies to operate our Service.
  • Preference Cookies. We use Preference Cookies to remember your preferences and various settings.
  • Security Cookies. We use Security Cookies for security purposes.

Use of Data

Force Science Institute, Ltd. uses the collected data for various purposes:

  • To provide and maintain the Service
  • To notify you about changes to our Service
  • To allow you to participate in interactive features of our Service when you choose to do so
  • To provide customer care and support
  • To provide analysis or valuable information so that we can improve the Service
  • To monitor the usage of the Service
  • To detect, prevent and address technical issues

Transfer Of Data

Your information, including Personal Data, may be transferred to — and maintained on — computers located outside of your state, province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.

If you are located outside United States and choose to provide information to us, please note that we transfer the data, including Personal Data, to United States and process it there.

Your consent to this Privacy Policy followed by your submission of such information represents your agreement to that transfer.

Force Science Institute, Ltd. will take all steps reasonably necessary to ensure that your data is treated securely and in accordance with this Privacy Policy and no transfer of your Personal Data will take place to an organization or a country unless there are adequate controls in place including the security of your data and other personal information.

Disclosure Of Data

Legal Requirements

Force Science Institute, Ltd. may disclose your Personal Data in the good faith belief that such action is necessary to:

  • To comply with a legal obligation
  • To protect and defend the rights or property of Force Science Institute, Ltd.
  • To prevent or investigate possible wrongdoing in connection with the Service
  • To protect the personal safety of users of the Service or the public
  • To protect against legal liability

Security Of Data

The security of your data is important to us, but remember that no method of transmission over the Internet, or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Data, we cannot guarantee its absolute security.

Service Providers

We may employ third party companies and individuals to facilitate our Service (“Service Providers”), to provide the Service on our behalf, to perform Service-related services or to assist us in analyzing how our Service is used.

These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.


We may use third-party Service Providers to monitor and analyze the use of our Service.

  • Google AnalyticsGoogle Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our Service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.You can opt-out of having made your activity on the Service available to Google Analytics by installing the Google Analytics opt-out browser add-on. The add-on prevents the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) from sharing information with Google Analytics about visits activity.For more information on the privacy practices of Google, please visit the Google Privacy & Terms web page: https://policies.google.com/privacy?hl=en

Links To Other Sites

Our Service may contain links to other sites that are not operated by us. If you click on a third party link, you will be directed to that third party’s site. We strongly advise you to review the Privacy Policy of every site you visit.

We have no control over and assume no responsibility for the content, privacy policies or practices of any third party sites or services.

Children’s Privacy

Our Service does not address anyone under the age of 18 (“Children”).

We do not knowingly collect personally identifiable information from anyone under the age of 18. If you are a parent or guardian and you are aware that your Children has provided us with Personal Data, please contact us. If we become aware that we have collected Personal Data from children without verification of parental consent, we take steps to remove that information from our servers.

Changes To This Privacy Policy

We may update our Privacy Policy from time to time. We will notify you of any changes by posting the new Privacy Policy on this page.

We will let you know via email and/or a prominent notice on our Service, prior to the change becoming effective and update the “effective date” at the top of this Privacy Policy.

You are advised to review this Privacy Policy periodically for any changes. Changes to this Privacy Policy are effective when they are posted on this page.

Contact Us

If you have any questions about this Privacy Policy, please contact us:

  • By email: support@forcescience.org
  • By visiting this page on our website: https://www.forcescience.org/contact
  • By phone number: 866-683-1944
  • By mail: Force Science Institute, Ltd.